Qatar flu diagnostic and treatment market is projected to grow at a CAGR of 18.11% throughout the forecast period. The flu diagnostic and treatment market in Qatar is projected to witness a noteworthy CAGR throughout the forecast period due to the fact that the country has been equipped with highly advanced healthcare facilities coupled with a high purchasing power of the consumers lets the consumers take proactive measures in order to predetermine the diseases, which is considered as on Read more...
Israel flu diagnostic and treatment market is projected to grow at a CAGR of 11.35% throughout the forecast period. The market for flu diagnostic and treatment in Israel is poised to surge at a noteworthy rate during the next five years as Israel is one of those nations with a high focus on healthcare. The spending of the country on the public healthcare is comparatively higher than in other countries of the Middle Eastern region. Furthermore, the highly advanced and state-of-art healthc Read more...
UAE flu diagnostic and treatment market is projected to grow at a CAGR of 5.68% throughout the forecast period. The market in the United Arab Emirates is poised to grow at a slow CAGR throughout the forecast period as the market growth in the country is primarily based on the seasonal outbreak of flu throughout the country only. Furthermore, the high purchasing power of the people coupled with the presence of a world-class healthcare of the country are also some of the factors which are Read more...
Iran flu diagnostic and treatment market is projected to grow at a CAGR of 5.14% throughout the forecast period. The country will is expected to grow at such rate owing to the growing adoption of more advanced treatments and better equipment as the country has witnessed an increasing number of deaths. The adoption of more advanced equipment in the healthcare sector to curb the rising intensity of seasonal flu and increasing number of deaths due to the same will be driving the market in Read more...
U.S. flu diagnostic and treatment market is projected to grow at a CAGR of 9.17% throughout the forecast period. According to the CDC (Center for Disease Control and Prevention), influenza is the leading cause of death by a vaccine-preventable disease and the eighth leading cause of death in the United States, together with pneumonia. Seasonal influenza results in more than US$10 billion of a total economic burden to the country’s healthcare system and society per year.The increasi Read more...
Sweden flu diagnostic and treatment market is projected to grow at a CAGR of 10.40% throughout the forecast period. The flu diagnostic and treatment market in Sweden is primarily driven by the high intensity of seasonal influenza in the country coupled with the presence of a well-established healthcare system of the country. The responsibility of healthcare in the country lies with the municipal governments and county councils. The healthcare of the country is decentralized. Furthermore, Read more...
Russia flu diagnostic and treatment market is projected to grow at a CAGR of 1.48% throughout the forecast period. The flu diagnostics and treatment market in Russia is poised to grow on account of the availability of a highly advanced healthcare system in the country. Russian government ensures that free health services are available adequately to the citizens of the country through via Obligatory Medical Insurance (OMI). In addition, the seasonal prevalence of influenza is also pr Read more...
Spain flu diagnostic and treatment market is expected to surge at a CAGR of 1.94% throughout the forecast period. The flu diagnostic and treatment market in Spain is anticipated to propel throughout the forecast period on account of the increasing government focus to for the improvement of access to healthcare services among the population of the country. Furthermore, the rising healthcare expenditure primarily for the adoption of technology for the improvement of the country’s hea Read more...
Norway flu diagnostic and treatment market is projected to grow at a CAGR of 4.89% throughout the forecast period. The rising prevalence of influenza is one of the key factors which is projected to bolster the flu diagnostic and treatment market growth in the country during the forecast period. The growing intensity of the influenza virus during the peak flu seasons is also considered as an important factor for the market growth in the coming years. According to the latest reports from t Read more...
Mexico flu diagnostic and treatment market is projected to grow at a CAGR of 3.90% throughout the forecast period. Despite the presence of vaccination programs in the country, influenza still represents a significant disease burden in Mexico. The rising incidence of seasonal influenza across the country is significantly driving the market growth of the flu diagnostic and treatment market in Mexico. The flu diagnostic and treatment market in Mexico is anticipated to grow on account of the Read more...
.jpg)
